Skip to main content

Peer Review reports

From: ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer

Original Submission
11 Aug 2015 Submitted Original manuscript
25 Dec 2015 Reviewed Reviewer Report - Stephanie Mcardle
28 Dec 2015 Reviewed Reviewer Report - Jae-Hyun Park
11 Mar 2016 Author responded Author comments - Kristina Magnusson
Resubmission - Version 2
11 Mar 2016 Submitted Manuscript version 2
14 Mar 2016 Reviewed Reviewer Report - Jae-Hyun Park
11 Aug 2016 Author responded Author comments - Kristina Magnusson
Resubmission - Version 3
11 Aug 2016 Submitted Manuscript version 3
7 Oct 2016 Author responded Author comments - Kristina Magnusson
Resubmission - Version 4
7 Oct 2016 Submitted Manuscript version 4
Publishing
2 Nov 2016 Editorially accepted
18 Nov 2016 Article published 10.1186/s12885-016-2923-8

You can find further information about peer review here.

Back to article page